US 11078227
5′-cyclo-phosphonate modified nucleotides
granted A61PA61P1/16A61P31/20
Quick answer
US patent 11078227 (5′-cyclo-phosphonate modified nucleotides) held by Arrowhead Pharmaceuticals, Inc. expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/16, A61P31/20